Potassium binders as enablers of guideline‐directed renin–angiotensin–aldosterone system inhibitor therapy
Journal of Internal Medicine · 2026-08 · 300 (2) · 106-109
DOI: 10.1111/joim.70100 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Internal Medicine, online erschienen am 18.05.2026. Verfasst von Carmine Zoccali und 1 weiteren Autor:innen. Beteiligte Einrichtung: Renal Research Institute, New York, New York, USA. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Renal Research Institute, New York, New York, USA.
- Institute of Molecular Biology and Genetics (Biogem), Ariano Irpino, Italy.
- Associazione Ipertensione Nefrologia Trapianto Renal (IPNET), Reggio Calabria, Italy.
ORCID-Profile: Carmine Zoccali, Francesca Mallamaci
Zitieren
APA
Zoccali, C., & Mallamaci, F. (2026). Potassium binders as enablers of guideline‐directed renin–angiotensin–aldosterone system inhibitor therapy. Journal of Internal Medicine, 300(2), 106-109. https://doi.org/10.1111/joim.70100
Vancouver
Zoccali C, Mallamaci F. Potassium binders as enablers of guideline‐directed renin–angiotensin–aldosterone system inhibitor therapy. Journal of Internal Medicine. 2026;300(2):106-109. doi:10.1111/joim.70100
BibTeX
@article{Zoccali2026,
author = {Zoccali, Carmine and Mallamaci, Francesca},
title = {Potassium binders as enablers of guideline‐directed renin–angiotensin–aldosterone system inhibitor therapy},
journal = {Journal of Internal Medicine},
year = {2026},
volume = {300},
number = {2},
pages = {106--109},
doi = {10.1111/joim.70100}
}
EUVIMED